EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Improvements in Therapy Experience With Evoked Compound Action Potential Controlled, Closed-Loop Spinal Cord Stimulation—Primary Outcome of the ECHO-MAC Randomized Clinical Trial

Andrew Will, Michael Fishman, David Schultz, Michael Danko, Daniel Verill, Christopher Davies, Patrick Retterath, Nathan Miller, Lisa Tonder, Lisa Johanek, David Dinsmoor, Ye Tan und 2 weitere

The Journal of Pain · 2024-11 · 25 (11) · 104646

DOI: 10.1016/j.jpain.2024.104646 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Pain, 2024-11. Verfasst von Andrew Will und 13 weiteren Autor:innen. Beteiligte Einrichtung: Twin Cities Pain Clinic, Edina, Minnesota. Electronic address: andrew.will@tcpain.com. Hauptthemen laut MEDLINE: Spinal Cord Stimulation, Cross-Over Studies, Neuralgia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medtronic Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord stimulation (SCS) is a well-established treatment for chronic neuropathic pain. However, over- or underdelivery of the SCS may occur because the spacing between the stimulating electrodes and the spinal cord is not fixed; spacing changes with motion and postural shifts may result in variable delivery of the SCS dose and, in turn, a suboptimal therapy experience for the patient. The evoked compound action potential (ECAP)-a measure of neural activation-may be used as a control signal to adapt SCS parameters in real time to compensate for this variability. In this prospective, multicenter, randomized, single-blind, crossover trial, reduction in overstimulation intensity was used as a perceptual measure to evaluate a novel ECAP-controlled, closed-loop (CL) SCS algorithm relative to traditional open-loop (OL) SCS. The primary outcome used a Likert scale to assess sensation during activities of daily living with CL versus OL SCS. Of the 42 subjects in the intent-to-treat analysis set, 97.6% had a reduction in sensation with CL versus OL SCS. The primary objective was met as the lower confidence limit (87.4%) exceeded the performance goal of 50% (P < .001). A total of 88.1% (37/42) of subjects preferred CL and 11.9% (5/42) preferred OL SCS. SCS dose consistency during CL SCS was demonstrated by the reduced variability in ECAP amplitude with CL SCS (standard deviation: 8.72 µV) relative to OL SCS (standard deviation: 19.95 µV). Together, these results demonstrate that the ECAP-controlled, CL algorithm reduces or eliminates unwanted sensation, and thereby provides a more preferred and consistent SCS experience. PERSPECTIVE: Patients with chronic pain need durable and dependable options for pain relief. SCS is an important therapy option, and new technology advancements could improve long-term therapy use. CL SCS offers a preferred and more consistent therapy experience for patients that could lead to increased therapy utilization and reliable therapy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord StimulationCross-Over StudiesNeuralgiaHumansMaleFemaleMiddle AgedSingle-Blind MethodAdultAgedChronic PainAction PotentialsTreatment OutcomeProspective Studies

Stichwörter der Autor:innen

Evoked compound action potentials, sensing, closed-loop spinal cord stimulation…

Autor:innen und Institutionen

  • Twin Cities Pain Clinic, Edina, Minnesota. Electronic address: andrew.will@tcpain.com.
  • Center for Pain Control, Wyomissing, Pennsylvania.
  • Nura Pain Clinics, Edina, Minnesota.
  • Premier Pain Treatment Institute, Mt Orab, Ohio.
  • Department of Anesthesiology, Kettering Medical Center, Kettering, Ohio.
  • Anethesia/Pain Management, Lakewalk Surgery Center, Duluth, Minnesota.

Förderung

  • Medtronic Inc

Zitieren

APA

Will, A., Fishman, M., Schultz, D., Danko, M., Verill, D., Davies, C., Retterath, P., Miller, N., Tonder, L., Johanek, L., Dinsmoor, D., Tan, Y., Franke, A., & Soghomonyan, S. (2024). Improvements in Therapy Experience With Evoked Compound Action Potential Controlled, Closed-Loop Spinal Cord Stimulation—Primary Outcome of the ECHO-MAC Randomized Clinical Trial. The Journal of Pain, 25(11), 104646. https://doi.org/10.1016/j.jpain.2024.104646

Vancouver

Will A, Fishman M, Schultz D, Danko M, Verill D, Davies C, et al. Improvements in Therapy Experience With Evoked Compound Action Potential Controlled, Closed-Loop Spinal Cord Stimulation—Primary Outcome of the ECHO-MAC Randomized Clinical Trial. The Journal of Pain. 2024;25(11):104646. doi:10.1016/j.jpain.2024.104646

BibTeX
@article{Will2024,
  author = {Will, Andrew and Fishman, Michael and Schultz, David and Danko, Michael and Verill, Daniel and Davies, Christopher and Retterath, Patrick and Miller, Nathan and Tonder, Lisa and Johanek, Lisa and Dinsmoor, David and Tan, Ye and Franke, Abi and Soghomonyan, Suren},
  title = {Improvements in Therapy Experience With Evoked Compound Action Potential Controlled, Closed-Loop Spinal Cord Stimulation—Primary Outcome of the ECHO-MAC Randomized Clinical Trial},
  journal = {The Journal of Pain},
  year = {2024},
  volume = {25},
  number = {11},
  pages = {104646},
  doi = {10.1016/j.jpain.2024.104646}
}
Kostenlos starten →